Oncotelic Therapeutics, Inc. (OTLC)
OTLC Stock Price Chart
Explore Oncotelic Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze OTLC price movements and trends.
OTLC Company Profile
Discover essential business fundamentals and corporate details for Oncotelic Therapeutics, Inc. (OTLC) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
26 Aug 1993
Employees
26.00
Website
https://www.oncotelic.comCEO
Vuong Trieu
Description
Oncotelic Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing drugs for the treatment of orphan oncology indications. The company's lead product candidate is OT-101, an antisense against TGF-ß2, which is in phase 3 clinical trials for pancreatic cancer and glioblastoma, as well as develops OT-101 for the treatment of various viruses, including severe acute respiratory syndrome and coronavirus. It also develops OXi4503 for the treatment of acute myeloid leukemia and myelodysplastic syndromes; and CA4P for the treatment of advanced metastatic melanoma. The company is headquartered in Agoura Hills, California.
OTLC Financial Timeline
Browse a chronological timeline of Oncotelic Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 May 2026
Upcoming earnings on 13 May 2026
Upcoming earnings on 17 Nov 2025
Earnings released on 13 Aug 2025
EPS came in at $0.00 .
Earnings released on 15 May 2025
EPS came in at -$0.00 .
Earnings released on 15 Apr 2025
EPS came in at -$0.00 .
Earnings released on 19 Nov 2024
EPS came in at -$0.01 .
Earnings released on 14 Aug 2024
EPS came in at -$0.00 .
Earnings released on 15 Apr 2024
EPS came in at -$0.00 .
Earnings released on 12 Apr 2024
EPS came in at -$0.00 .
Earnings released on 14 Nov 2023
EPS came in at $0.00 , while revenue for the quarter reached $70.00K .
Earnings released on 18 Aug 2023
EPS came in at -$0.02 .
Earnings released on 17 Apr 2023
EPS came in at -$0.01 .
Earnings released on 14 Apr 2023
EPS came in at -$0.01 .
Earnings released on 21 Nov 2022
EPS came in at -$0.00 .
Earnings released on 22 Aug 2022
EPS came in at $0.04 .
Earnings released on 23 May 2022
EPS came in at -$0.01 falling short of the estimated -$0.01 by -100.00%.
Earnings released on 18 Apr 2022
EPS came in at -$0.00 surpassing the estimated -$0.01 by +51.60%.
Earnings released on 22 Nov 2021
EPS came in at -$0.00 falling short of the estimated -$0.00 by -100.00%.
Earnings released on 20 Aug 2021
EPS came in at -$0.01 .
Earnings released on 24 May 2021
EPS came in at -$0.03 falling short of the estimated -$0.02 by -50.00%.
Earnings released on 15 Apr 2021
EPS came in at -$0.04 falling short of the estimated -$0.02 by -166.67%, while revenue for the quarter reached -$1.74M .
Earnings released on 16 Nov 2020
EPS came in at -$0.02 .
OTLC Stock Performance
Access detailed OTLC performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.